Pyrrolo[2,3-d]pyrimidin-4-ol

We are Pyrrolo[2,3-d]pyrimidin-4-ol CAS:3680-71-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Pyrrolo[2,3-d]pyrimidin-4-ol
CAS.NO:3680-71-5
Synonyms:Pyrrolo[2,3-d]pyrimidin-4-ol
7-Deazahypoxanthine
4-Hydroxypyrrolo[2,3-d]pyrimidine
1H-Pyrrolo[2,3-d]pyrimidin-4(7H)-one
3,7-Dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
1,7-dihydropyrrolo[2,3-d]pyrimidin-4-one
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 473.1±18.0 °C at 760 mmHg
Melting Point 345-348ºC
Molecular Formula C6H5N3O
Molecular Weight 135.123
Flash Point 239.9±21.2 °C
 
Specification:
Appearance:Brown powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Tofacitinib(CAS:477600-75-2).

Pyrrolo[2,3-d]pyrimidin-4-ol


Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.(3R,4S)-1-benzoyl-4-phenyl-3-triethylsilyloxyazetidin-2-one Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.93-71-0 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.1-(4-aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.

Related Products
Product Name
1,3-Adamantanedicarboxylic Acid Cas:39269-10-8 View Details
CERIUM(III) 2-ETHYLHEXANOATE Cas:56797-01-4 View Details
CORN OIL Cas:8001-30-7 View Details
Carbamic Acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, Ethyl Este Cas:1869118-24-0 manufacturer 2′,2′-Difluoro-2′-deoxycytidine-3′,5′-dibenzoate manufacturer (1R,3S)-3-mercaptotetrahydrothiophene 1-oxide Cas:127941-63-3 manufacturer 1,2,3-Tribromopropane manufacturer Cesium formate Cas:3495-36-1 manufacturer